Podcast TCTMD Talking Points POPULAR TAVI C. Michael Gibson and Jorn Brouwer discuss aspirin with or without clopidogrel after transcatheter aortic valve replacement.
Podcast TCTMD Talking Points EMPEROR Reduced C. Michael GIbson and Milton Packer Discuss empagliflozin in heart failure with reduced ejection fraction.
Podcast TCTMD Talking Points Talking Points: New ESC NSTEMI Guidelines C. Michael Gibson and Roxana Mehran discuss new ESC NSTEMI guidelines and more.
Podcast TCTMD Talking Points Innovation in Mitral Valve Repair C. Michael Gibson and Steven Goldberg discuss REDUCE-FMR and sham-controlled trials in MV repair.
Podcast TCTMD Talking Points PARTNER 2A: 5-Year Outcomes C. Michael Gibson and Vinod Thourani discuss 5-year outcomes in this randomized trial of TAVR vs SAVR in intermediate-risk patients.
Podcast TCTMD Talking Points COAPT Cost-effectiveness Analysis Plus Health-Status Outcomes in PARTNER 3 Suzanne Baron and C. Michael Gibson discuss important new details from these two structural heart disease trials.
Podcast TCTMD Talking Points EVOLVE Short DAPT: 3-Month DAPT in Patients at High Bleeding Risk Treated with a Bioabsorbable Polymer-Based Everolimus-Eluting Stent C. Michael Gibson and Ajay Kirtane review the results of this single-arm stent study.
Podcast TCTMD Talking Points #WomenAs1: The Battle for Gender Equality Roxana Mehran brings C. Michael Gibson up to speed on a campaign to promote talent in medicine by offering professional opportunities to female physicians.
Podcast TCTMD Talking Points TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI Usman Baber, who led this thrombogenicity substudy, walks C. Michael Gibson through the key findings.
Podcast TCTMD Talking Points IVUS-XPL: Intravascular Ultrasound-Guided vs. Angiography-Guided PCI of Long Coronary Lesions C. Michael Gibson and Myeong-Ki Hong discuss 5-year outcomes in this randomized trial.